Journal of Chemical and Pharmaceutical Research (ISSN : 0975-7384)

Reach Us reach to JOCPR whatsapp-JOCPR +44 1625708989
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Original Articles: 2015 Vol: 7 Issue: 7

Development and validation of stability indicating RP-LC method for estimation of celecoxib (CXB) in microemulsion capsule formulations


An isocratic reverse phase liquid chromatography (RP-LC) method has been developed and subsequently validated for the determination of Celecoxib in Bulk and its pharmaceutical formulation. Separation was achieved with a Symmetry RP-18 ((Make: Waters Corporation; 75 mmx4.6 mm I.D; particle size 5 μm)) Column and Potassium dihydrogen phosphate monohydrate buffer (pH adjusted to 3.0 with diluted orthophosphoric acid): methanol: acetonitrile (400:400:200) v/v as eluent at a flow rate of 0.8 mL/min. UV detection was performed at 225nm. The method is simple, rapid, and selective. The described method of Celecoxib is linear over a range of 25 μg/mL to 75 μg/mL. The method precision for the determination of assay was below 1.0% RSD. The percentage recoveries of active pharmaceutical ingredient (API) from dosage forms ranged from 98 to 102%. The results showed that the proposed method is suitable for the precise, accurate and rapid determination of Celecoxib in bulk, its capsule dosage forms.